// App-Quantinova.ai

PB1047 : Immune Tolerance Induction with Simoctocog Alfa in Patients with Haemophilia A: An Ongoing Multicentre Case Series from the UK

Researchers

Presenter

  • G.W. Hall

Principal Investigators

  • A. Wilkinson

  • M. Mathias

  • N. Bhatnagar

  • T. Biss

  • R.J. Liesner

Medical Centers

  • Children's Hospital Oxford, Oxford Haemophilia and Thrombosis Comprehensive Care Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom

  • Haemophilia Comprehensive Care Centre, Great Ormond Street Hospital for Children, London, United Kingdom

  • Newcastle Haemophilia Comprehensive Care Centre, The Newcastle upon Tyne Hospitals NHS Foundation Trust,Newcastle,United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Hemophilia

Biomarkers

  • Alpha-1-microglobulin/bikunin precursor

Drug/Treatment

  • simoctocog alfa

  • FVIII

Outcome

  • N/A

Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved